Ap. Kennedy et al., COVALENT MODIFICATION OF TRANSMEMBRANE SPAN-III OF THE A(1) ADENOSINERECEPTOR WITH AN ANTAGONIST PHOTOAFFINITY PROBE, Molecular pharmacology, 50(4), 1996, pp. 789-798
Structure-based design of subtype-selective ligands for the A(1) adeno
sine receptor will require a reliable model of the ligand-binding pock
et. It should be possible to develop a reliable model based on the res
ults of affinity labeling experiments that provide atomic coordinates
for the ligand in relation to predicted receptor helices. A high affin
ity, A(1)-selective xanthine antagonist photoaffinity probe, (4-azidop
henethyl)-1-propyl-8-cyclopentylxanthine, was used to covalently modif
y the A(1) receptor. Chemical or enzymatic fragmentation experiments w
ere performed to localize the region or regions of incorporation withi
n the receptor. The fragmentation profiles for radiolabeled A(1) recep
tor obtained with endoproteinase Glu-C, endoproteinase Lys-C, cyanogen
bromide, and hydroxylamine were consistent with the interpretation th
at the covalent linkage was within the first four predicted transmembr
ane regions. This interpretation was confirmed by the demonstration th
at the radioactive endoproteinase Glu-C fragment derived from an A(1)
receptor that contains an amino-terminal FLAG epitope was recognized b
y an anti-FLAG monoclonal antibody. Sequential digestion with endoprot
einase Glu-C/endoproteinase Lys-C limited the possible labeling to the
first three predicted transmembrane spans, and endoproteinase Glu-C/t
rypsin digestion refined this prediction to include only transmembrane
spans III and IV. Taken together, our findings suggest that the adeno
sine antagonist (4-azidophenethyl)-1-propyl-8-cyclopentyl-xanthine cov
alently modifies transmembrane III of the A(1) receptor because this w
as the only receptor region common to all radiolabeled fragments.